FSNUF - Fresenius Medical Care: I Believe The Company Will 'Pop' In 2024-2026

2024-07-19 03:17:43 ET

Summary

• Despite risks, this company's future looks promising with solid revenue growth, cost savings, and market leadership in the kidney care sector.
• Fresenius Medical Care has shown volatility in share price but has confirmed organic growth and better-than-expected earnings.
• The company is undervalued and has the potential for slow appreciation and dividends.

Dear readers/followers,

In this article, I'm going to be updating on and taking a closer look at the future potential of Fresenius Medical Care ( OTCPK:FMCQF ) (FMS). The company has seen a bit of recovery in the share price, only to then crater and drop once again. There's considerable volatility in the recent trends - even if the latest results reflect a confirmed organic growth thesis, successful execution of the turnaround plan, and better-expected earnings.

The company continues to chug along at relatively average rates of profitability - but there is upward potential here....

For further details see: